Diabetes: Therapy for gestational diabetes mellitus--time for a change?

Peter Damm; Elisabeth R Mathiesen

doi:10.1038/nrendo.2015.54

Diabetes: Therapy for gestational diabetes mellitus--time for a change?

Peter Damm, Elisabeth R Mathiesen

Institut for Klinisk Medicin

7 Citationer (Scopus)

Abstract

For >30 years, insulin has been the drug of choice for the medical treatment of gestational diabetes mellitus. However, the use of oral hypoglycaemic agents has increased during the past 1–2 decades, so a recent comparison of treatment with glibenclamide, metformin or insulin in women with gestational diabetes mellitus is highly relevant.

Originalsprog	Engelsk
Tidsskrift	Nature Reviews Endocrinology
Vol/bind	11
Udgave nummer	6
Sider (fra-til)	327-8
Antal sider	2
ISSN	1759-5029
DOI	https://doi.org/10.1038/nrendo.2015.54
Status	Udgivet - 26 jun. 2015

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

10.1038/nrendo.2015.54

Citationsformater

@article{beac9e1e836c415ba7bb140cd4c4c683,

title = "Diabetes: Therapy for gestational diabetes mellitus--time for a change?",

abstract = "For >30 years, insulin has been the drug of choice for the medical treatment of gestational diabetes mellitus. However, the use of oral hypoglycaemic agents has increased during the past 1–2 decades, so a recent comparison of treatment with glibenclamide, metformin or insulin in women with gestational diabetes mellitus is highly relevant.",

keywords = "Diabetes, Gestational, Female, Glyburide, Humans, Hypoglycemic Agents, Insulin, Metformin, Pregnancy",

author = "Peter Damm and Mathiesen, {Elisabeth R}",

year = "2015",

month = jun,

day = "26",

doi = "10.1038/nrendo.2015.54",

language = "English",

volume = "11",

pages = "327--8",

journal = "Nature Reviews Endocrinology",

issn = "1759-5029",

publisher = "nature publishing group",

number = "6",

}

TY - JOUR

T1 - Diabetes

T2 - Therapy for gestational diabetes mellitus--time for a change?

AU - Damm, Peter

AU - Mathiesen, Elisabeth R

PY - 2015/6/26

Y1 - 2015/6/26

N2 - For >30 years, insulin has been the drug of choice for the medical treatment of gestational diabetes mellitus. However, the use of oral hypoglycaemic agents has increased during the past 1–2 decades, so a recent comparison of treatment with glibenclamide, metformin or insulin in women with gestational diabetes mellitus is highly relevant.

AB - For >30 years, insulin has been the drug of choice for the medical treatment of gestational diabetes mellitus. However, the use of oral hypoglycaemic agents has increased during the past 1–2 decades, so a recent comparison of treatment with glibenclamide, metformin or insulin in women with gestational diabetes mellitus is highly relevant.

KW - Diabetes, Gestational

KW - Female

KW - Glyburide

KW - Humans

KW - Hypoglycemic Agents

KW - Insulin

KW - Metformin

KW - Pregnancy

U2 - 10.1038/nrendo.2015.54

DO - 10.1038/nrendo.2015.54

M3 - Journal article

C2 - 25850660

SN - 1759-5029

VL - 11

SP - 327

EP - 328

JO - Nature Reviews Endocrinology

JF - Nature Reviews Endocrinology

IS - 6

ER -

Diabetes: Therapy for gestational diabetes mellitus--time for a change?

Abstract

FN’s Verdensmål

Adgang til dokumentet

Fingeraftryk

Citationsformater